BioPharma Resources

Drug Trial Radar · NCT07213804

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

FRAmework-01: A Three-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) Versus Chemotherapy or Mirvetuximab Soravtansine in Platinum-Resistant Ovarian Cancer, and Sofetabart Mipitecan Plus Bevacizumab Versus Platinum-Based Chemotherapy Plus Bevacizumab in Platinum-Sensitive Ovarian Cancer.

Last checked: Nov 19, 2026Latest source record: Nov 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 1,630 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

1,630

Planned (sponsor's estimate)

Start

Oct 22, 2025

Primary completion

Nov 2028

Study completion Aug 2031

Sponsor

Lead sponsor
Eli Lilly and CompanyEli Lilly (LLY)
Sponsor type
Industry
Collaborators
GOG Foundation; European Network of Gynaecological Oncological Trial Groups (ENGOT); Asia-Pacific Gynecologic Oncology Trials Group
First posted
Oct 9, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a clinical study that has three parts. It is testing a potential new medicine called Sofetabart Mipitecan (Sofe-M) for people with certain types of ovarian, peritoneal, and fallopian tube cancers. Part A enrolls participants with platinum-resistant cancer, meaning their disease progressed during or within six months of platinum-based chemotherapy. Parts B and C enroll participants with platinum-sensitive cancer, whose disease responded and remained controlled for at least six months after completing platinum treatment. The researchers want to find out if Sofe-M works better than the standard treatments that doctors use now and to better understand how safe it is. Each participant's time in the study will depend on how they respond to the treatment.

Conditions

  • Ovarian Neoplasms
  • Fallopian Tube Neoplasms
  • Peritoneal Neoplasms
  • Neoplasm Metastasis

Interventions

  • Sofetabart MipitecanDrug

    Administered IV

  • PaclitaxelDrug

    Administered IV

  • TopotecanDrug

    Administered IV

  • GemcitabineDrug

    Administered IV

  • Pegylated liposomal doxorubicin (PLD)Drug

    Administered IV

  • MIRVDrug

    Administered IV

  • BevacizumabDrug

    Administered IV

  • CarboplatinDrug

    Administered IV

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Progression-free Survival (PFS) per Response Evaluation Criteria in Solid Tumors (RECIST) v1.1 by InvestigatorTime frame: Randomization to radiographic progression or death from any cause (up to 70 months)
  2. PFS per Response Evaluation Criteria in Solid Tumors (RECIST) v1.1 by Blinded, Independent, Central Review (BICR)Time frame: Randomization to radiographic progression or death from any cause (up to 70 months)

Locations

264 sites in 27 countries. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham

    Birmingham, Alabama · Not yet recruiting

  • HonorHealth

    Phoenix, Arizona · Recruiting

  • Roy and Patricia Disney Family Cancer Center - Providence Saint Joseph Medical Center

    Burbank, California · Recruiting

  • City of Hope, Duarte

    Duarte, California · Recruiting

  • City of Hope Lennar

    Irvine, California · Recruiting

  • Kaiser Permanente Zion Medical Center

    Irvine, California · Recruiting

  • Moores Cancer Center

    La Jolla, California · Not yet recruiting

  • UCLA Hematology/Oncology - Westwood (Building 100)

    Los Angeles, California · Recruiting

  • Stanford Women's Cancer Center

    Palo Alto, California · Recruiting

  • Sansum Clinic

    Santa Barbara, California · Recruiting

  • Kaiser Permanente

    Vallejo, California · Not yet recruiting

  • Anschutz Cancer Pavilion

    Aurora, Colorado · Recruiting

  • AdventHealth Medical Group - Porter

    Denver, Colorado · Recruiting

  • UConn Health

    Farmington, Connecticut · Recruiting

  • Broward Health Medical Center

    Fort Lauderdale, Florida · Recruiting

  • Florida Cancer Specialist- South

    Fort Myers, Florida · Recruiting

  • Baptist MD Anderson Cancer Center

    Jacksonville, Florida · Recruiting

  • University of Miami Hospital and Clinics, Sylvester Cancer Center

    Miami, Florida · Recruiting

  • Mount Sinai Braman Comprehensive Cancer Center

    Miami Beach, Florida · Recruiting

  • AdventHealth Orlando

    Orlando, Florida · Recruiting

  • Moffitt Cancer Center

    Tampa, Florida · Not yet recruiting

  • Florida Cancer Specialist- East

    West Palm Beach, Florida · Recruiting

  • Winship Cancer Institute, Emory University

    Atlanta, Georgia · Recruiting

  • Nancy N. & J.C. Lewis Cancer and Research Pavillion

    Savannah, Georgia · Recruiting

  • Kapiolani Medical Center for Women and Children

    Honolulu, Hawaii · Not yet recruiting

  • Illinois Cancer Specialists

    Arlington Heights, Illinois · Recruiting

  • Northwestern Memorial Hospital

    Chicago, Illinois · Recruiting

  • Rush University Medical Center

    Chicago, Illinois · Not yet recruiting

  • The University of Chicago Medicine

    Chicago, Illinois · Not yet recruiting

  • OSF Saint Fracis Medical Center

    Peoria, Illinois · Recruiting

  • Indiana University Melvin and Bren Simon Cancer Center

    Indianapolis, Indiana · Recruiting

  • Franciscan Health

    Indianapolis, Indiana · Recruiting

  • Baptist Health Lexington

    Lexington, Kentucky · Recruiting

  • University of Kentucky Chandler Medical Center

    Lexington, Kentucky · Not yet recruiting

  • Norton Women's and Children's Hospital

    Louisville, Kentucky · Recruiting

  • Ochsner Clinic Foundation

    New Orleans, Louisiana · Recruiting

  • Trials 365

    Shreveport, Louisiana · Recruiting

  • Maine Medical Center - Scarborough Campus

    Scarborough, Maine · Recruiting

  • Greater Baltimore Medical Center

    Baltimore, Maryland · Recruiting

  • Sinai Hospital Of Baltimore

    Baltimore, Maryland · Recruiting

Showing 40 of 264 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.